MHRA Class 2 Medicines Recall: Olopatadine USV 1mg/ml eye drops (USV UK Limited)

Class 2 Medicines recall: Olopatadine USV 1mg/ml eye drops (USV UK Limited)

Drug alert number: EL (22) A/17

Date issued: 11th April 2022

The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a class 2 medicines recall for:

Olopatadine USV 1mg/ml eye drops (USV UK Limited) PL 32870/0055

USV UK Limited are recalling the affected batches as a precautionary measure due to out of specification
results for impurities during routine stability testing. The company’s investigation is on-going.

Batch Number Expiry Date Pack Size First Distributed
35000201 07/2023 5ml 14 July 2021
35000202 07/2023 5ml 27 July 2021
35000203 07/2023 5ml 5 August 2021
35000204 07/2023 5ml 29 November 2021
35000206 07/2023 5ml 23 July 2021

Advice for healthcare professionals

Stop supplying the above batches immediately. Quarantine all remaining stock and return it to your supplier using your supplier’s approved process.

Full drug alert can be viewed here.

Company contacts for further information

For more information, medical or supply enquiries, please contact

Discover how we are working to improve the outlook for community pharmacy at an event near you.

Click Here